生物标志物 生物标志物
Muhammad Ali1,2, Yike Chen1,2, Ying Xu1,2
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
这项研究分析了9963名患有神经退行性疾病 (ND) 的个体的血蛋白质组概况. 阿尔茨海默氏症,帕金森氏症和前性痴呆症显示出明显的蛋白质变化,促进了对这些疾病的理解.
科学领域:
- 神经科学是一个神经科学.
- 蛋白质组学是指蛋白质组学.
- 生物化学 生物化学
背景情况:
- 全球神经退行性蛋白质组学联盟 (GNPC) 通过协作蛋白质组分析研究神经退行性疾病 (ND).
- 这项研究介绍了一项横截面分析工作流的初步发现,该工作流检查了9963名个体的血蛋白质组概况.
研究的目的:
- 在阿尔茨海默病 (AD),帕金森病 (PD) 和前性痴呆症 (FTD) 中识别疾病特异性血蛋白质组签名.
- 为了进一步了解神经退行症的分子基础.
- 探索精确疾病亚型的机会.
主要方法:
- 使用了一组多样化的ND队列,包括AD,PD和FTD样本.
- 使用 SomaScan 平台测量了多达 7,288 个分析物的蛋白质表达水平.
- 采用线性回归模型来比较ND组和对照组之间的血蛋白水平,调整共变量并使用多重测试的错误发现率.
主要成果:
- 阿尔茨海默病 (AD) 显示出最广泛的蛋白质基因变化 (>1,000个分析结果),SPC25和SMOC1.1的升高.
- 帕金森病 (PD) 呈现了超过150种改变的分析物,包括增加的PCBP3和SUMF1.
- 前性痴呆症 (FTD) 显示了50多种显著变化,NPTXR和OMG.R降低. AD和PD共享了最重叠的差异丰富的蛋白质.
结论:
- GNPC的横截面蛋白质组分析是神经退行性疾病研究的重大进展.
- 通过对不同疾病的蛋白质组数据进行比较,可以更好地理解神经退行症的分子基础.
- 这些发现为更精确,更准确的神经退行性疾病亚型化开辟了道路.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516